FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and pharmaceuticals and constitutes a niosomal antimicrobial gel for treating diabetic ulcers, wounds, and burns, including the use of encapsulated peptides; said gel is characterised by containing, encapsulated in organosilicon niosomes, defensins isolated from leukocyte-erythrocyte-thrombocyte blood mass, and low molecular weight peptides isolated from the amniotic membrane of animal-based placenta, as well as the Salcare SC80 gelling agent and triethanolamine. In a particular case, said ulcers, wounds, or burns are infected with antibiotic-resistant microorganisms.
EFFECT: invention solves the problem of increasing the effectiveness of regeneration and reducing the terms of treatment of diabetic ulcers.
2 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIMICROBIAL GEL FOR THE TREATMENT OF INFECTED WOUNDS, BURNS AND TROPHIC ULCERS | 2017 |
|
RU2655522C1 |
| METHOD FOR MAKING TRANSDERMAL PATCH CONTAINING PEG-12 DIMETHICONE NIOSOMES | 2012 |
|
RU2539397C2 |
| METHOD OF OBTAINING NIOSOMAL FORM OF GENTAMICIN | 2023 |
|
RU2805933C1 |
| OPTIMIZED RELEASE OF ENDOGENOUS BETA-DEFENSINS | 2024 |
|
RU2825572C1 |
| METHOD OF ISOLATING ENDOGENOUS ANTIMICROBIAL PEPTIDES FROM PLACENTAL TISSUE | 2022 |
|
RU2813979C2 |
| METHOD FOR TRANSDERMAL TRANSFER OF ACTIVE SUBSTANCES WITH USE OF PEG-12 DIMETHICONE NIOSOMES | 2012 |
|
RU2539396C2 |
| COMPOSITE FOR ACCELERATED HEALING OF WOUNDS OF VARIOUS AETIOLOGIES, USE OF COMPOSITE AS COSMETIC AGENT AND AS A THERAPEUTIC AGENT IN VETERINARY SCIENCE, AGENT FOR SKIN REGENERATION BASED ON COMPOSITE | 2017 |
|
RU2693228C2 |
| DOXORUBICIN AND ORGANOSILICON NANOPARTICLES-NIOSOMES- BASED PHARMACEUTICAL GEL FOR SKIN CANCER TREATING | 2014 |
|
RU2600164C2 |
| METHOD OF PHARMACOLOGICAL CORRECTION OF POST-TRAUMATIC DISORDERS OF IMMUNITY AND REPARATIVE PROCESSES IN EXPERIMENT | 2018 |
|
RU2698801C1 |
| PHARMACEUTICAL NIOSOMAL GEL BASED ON N-HYDROXY-2-(2-(NAPHTALENE-2-YL)-1H-INDOLE-3-YL)-2-PHENYLACETAMIDE WITH ANTI-TUMOUR ACTIVITY TO GLIOBLASTOMA | 2015 |
|
RU2627449C2 |
